Deming Sun Selected Research

Adenosine (Adenocard)

1/2023	The Role of Adenosine in γδ T-Cell Regulation of Th17 Responses in Experimental Autoimmune Uveitis.
7/2022	Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells' T helper 17 polarization.
1/2022	TLR ligand ligation switches adenosine receptor usage of BMDCs leading to augmented Th17 responses in experimental autoimmune uveitis.
1/2021	Timing Effect of Adenosine-Directed Immunomodulation on Mouse Experimental Autoimmune Uveitis.
1/2021	Adenosine receptor ligation tips the uveitogenic Th1 and Th17 balance towards the latter in experimental autoimmune uveitis-induced mouse.
1/2021	Augmented Th17-stimulating activity of BMDCs as a result of reciprocal interaction between γδ and dendritic cells.
1/2018	Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis.
1/2016	CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis.
12/2015	A2B adenosine receptor activation switches differentiation of bone marrow cells to a CD11c(+)Gr-1(+) dendritic cell subset that promotes the Th17 response.
12/2014	Anti-inflammatory or proinflammatory effect of an adenosine receptor agonist on the Th17 autoimmune response is inflammatory environment-dependent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deming Sun Research Topics

Disease

40	Uveitis 04/2024 - 11/2002
21	Inflammation (Inflammations) 04/2024 - 02/2003
10	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 06/2003
3	Dacryocystitis (Dacryoadenitis) 01/2023 - 01/2020
3	Dry Eye Syndromes (Dry Eye Syndrome) 01/2023 - 01/2020
3	Encephalomyelitis (Myeloencephalitis) 08/2004 - 11/2002
2	Keratitis 01/2024 - 01/2012
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2022 - 01/2018
2	Neoplasms (Cancer) 09/2007 - 09/2005
2	Anterior Uveitis 11/2002 - 11/2002
1	Infections 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2014
1	Experimental Arthritis 03/2013
1	Hypersensitivity (Allergy) 12/2009
1	Keratoconjunctivitis Sicca 05/2009
1	Disease Susceptibility (Diathesis) 03/2009
1	Communicable Diseases (Infectious Diseases) 09/2007
1	Optic Neuritis (Retrobulbar Neuritis) 11/2004
1	Paralysis (Palsy) 02/2003
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2002

Drug/Important Bio-Agent (IBA)

12	interstitial retinol-binding proteinIBA 12/2021 - 06/2003
10	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 12/2014
10	Peptides (Polypeptides)IBA 12/2021 - 11/2002
8	AntigensIBA 04/2024 - 11/2002
7	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2023 - 01/2014
7	Retinaldehyde (Retinal)IBA 01/2021 - 02/2006
7	Interleukin-17 (Interleukin 17)IBA 11/2016 - 03/2009
5	LigandsIBA 01/2024 - 01/2012
5	CytokinesIBA 12/2021 - 03/2009
3	Therapeutic UsesIBA 01/2023 - 01/2016
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2016
3	Adenosine DeaminaseIBA 01/2021 - 03/2016
3	HMGB1 Protein (HMG1)IBA 01/2017 - 04/2014
3	Myelin-Oligodendrocyte GlycoproteinIBA 11/2004 - 11/2002
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2024 - 01/2022
2	EnzymesIBA 01/2021 - 01/2016
2	AutoantigensIBA 02/2012 - 05/2009
2	Proteins (Proteins, Gene)FDA Link 06/2003 - 02/2003
1	dimethyl itaconateIBA 04/2024
1	FlagellinIBA 01/2024
1	CPG-oligonucleotideIBA 01/2024
1	Butyrates (Butyrate)IBA 01/2024
1	Poly I-CIBA 01/2024
1	ThymosinIBA 01/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022
1	EndotoxinsIBA 01/2021
1	Volatile Fatty AcidsIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	1-nitrosoindole-3-acetonitrileIBA 12/2019
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2016
1	2',3'-dialdehyde ATPIBA 01/2016
1	Adenosine Monophosphate (AMP)IBA 01/2016
1	insulin B (9-23)IBA 08/2014
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2014
1	Interleukin-23 (Interleukin 23)IBA 08/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2013
1	Hormones (Hormone)IBA 01/2012
1	Toll-Like Receptor 3IBA 01/2012
1	Interleukin-10 (Interleukin 10)IBA 03/2011
1	VaccinesIBA 09/2007
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 04/2006
1	Leukotriene B4IBA 04/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2005
1	OligodeoxyribonucleotidesIBA 11/2003
1	Lymphotoxin-alpha (Lymphotoxin)IBA 06/2003
1	Lymphotoxin beta ReceptorIBA 06/2003
1	Amino Acids FDA Link 02/2003
1	Myelin Basic ProteinIBA 11/2002
1	B7 AntigensIBA 11/2002
1	Myelin ProteinsIBA 11/2002

Therapy/Procedure

4	Therapeutics 04/2024 - 11/2003
2	Ligation 01/2022 - 01/2021
1	Topical Administration 01/2023
1	Immunomodulation 01/2021
1	Transjugular Intrahepatic Portasystemic Shunt 01/2021
1	Intraocular Injections 12/2009
1	Intracameral Injection 12/2009